CoCl(2) inhibits neural differentiation of retinoic acid-treated embryoid bodies

J Biosci Bioeng. 2008 Aug;106(2):141-7. doi: 10.1263/jbb.106.141.

Abstract

The effects of CoCl(2) on retinoic acid (RA)-treated embryoid bodies (EBs) were investigated. Four-day EBs were treated with 5x10(-6) M of RA for 4 d, then subjected to attached culturing for 7 d in the presence of CoCl(2) at 0, 20, and 100 microM. Differentiation into MAP2- and GFAP-immunopositive cells was inhibited by CoCl(2) in a dose-dependent manner. Next, RA-treated EBs were dissociated into single cells and cultured for 7 d at an initial cell density of 1x10(3)/cm(2). The number of cells increased in a CoCl(2)-dose dependent fashion. In cultures with 100 microM of CoCl(2), more than 90% of the cells were immunopositive for nestin and nestin-immunopositive cells formed clusters, while there were few cells immunopositive for MAP2 or GFAP. These results suggest that CoCl(2) inhibits neural differentiation of RA-treated EB cells and promotes the proliferation of nestin-immunopositive cells, i.e., embryonic stem (ES)-derived neural stem-like cells.

MeSH terms

  • Animals
  • Base Sequence
  • Cell Differentiation / drug effects*
  • Cell Proliferation
  • Cobalt / pharmacology*
  • DNA Primers
  • Dose-Response Relationship, Drug
  • Embryonic Stem Cells / cytology
  • Embryonic Stem Cells / drug effects*
  • Immunohistochemistry
  • Neurons / cytology
  • Neurons / drug effects*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tretinoin / pharmacology*

Substances

  • DNA Primers
  • Cobalt
  • Tretinoin
  • cobaltous chloride